1.6. Analysis.

Comparison 1 BDP v BUD crossover design studies, no OCS: all doses, Outcome 6 FVC (% predicted, litre measures combined).

Comparison 1 BDP v BUD crossover design studies, no OCS: all doses, Outcome 6 FVC (% predicted, litre measures combined).